Добронравов Владимир Александрович


Сортировать:

VD-266/MN ClinicalTrials.gov

Статус: Recruiting
Фаза: N/A
Начало: 1 мая 2018 г.
Окончание: 31 августа 2024 г.
Описание: This exploratory study aims to assess the efficacy, safety of the experimental treatment based on a combination of rituximab (RTX), intravenous (IV) cyclophosphamide (CYC), and corticosteroids (S) administrated at lower cumulative doses (RCP) for the induction of early remission in subjects with anti-PLA2R antibody-positive primary membranous nephropathy (PMN) having nephrotic syndrome (NS).
смотреть на ClinicalTrials.gov

VD285/IgAN/TE+IST ClinicalTrials.gov

Статус: Recruiting
Фаза: N/A
Начало: 10 марта 2013 г.
Окончание: 10 декабря 2027 г.
Описание: The open-label prospective non-randomised controlled aims to assess the efficacy of the combination of immunosupression (IST) and tonsillectomy (TE) in Caucasian patients at high risk of the IgA-nephropathy.
смотреть на ClinicalTrials.gov